Nicole Erin Kinsey White

Array ( [id] => 5655243 [patent_doc_number] => 20060140978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Genetic constructs and compositions comprising pre and cte and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/535326 [patent_app_country] => US [patent_app_date] => 2003-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2798 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140978.pdf [firstpage_image] =>[orig_patent_app_number] => 10535326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230096 [patent_doc_number] => 20040156831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Bacteriophage having modified holin and uses thereof' [patent_app_type] => new [patent_app_number] => 10/714591 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12933 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156831.pdf [firstpage_image] =>[orig_patent_app_number] => 10714591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107669 [patent_doc_number] => 20070066547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Ligands' [patent_app_type] => utility [patent_app_number] => 10/534259 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7124 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066547.pdf [firstpage_image] =>[orig_patent_app_number] => 10534259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333169 [patent_doc_number] => 20040131595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Treating carcinoid neoplasms with therapeutic viruses' [patent_app_type] => new [patent_app_number] => 10/700143 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3658 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131595.pdf [firstpage_image] =>[orig_patent_app_number] => 10700143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177528 [patent_doc_number] => 07655235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/533734 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 34 [patent_no_of_words] => 16252 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655235.pdf [firstpage_image] =>[orig_patent_app_number] => 10533734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656485 [patent_doc_number] => 20060142221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/533841 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 15103 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142221.pdf [firstpage_image] =>[orig_patent_app_number] => 10533841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5188093 [patent_doc_number] => 20070166401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Anticancer or antiviral composition' [patent_app_type] => utility [patent_app_number] => 10/510727 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10030 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166401.pdf [firstpage_image] =>[orig_patent_app_number] => 10510727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7263854 [patent_doc_number] => 20040241825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages' [patent_app_type] => new [patent_app_number] => 10/475195 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8028 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241825.pdf [firstpage_image] =>[orig_patent_app_number] => 10475195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069041 [patent_doc_number] => 20050244424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Carbohydrate-based synthetic vaccines for hiv' [patent_app_type] => utility [patent_app_number] => 10/531124 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15049 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244424.pdf [firstpage_image] =>[orig_patent_app_number] => 10531124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334391 [patent_doc_number] => 07507803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Optimized multi-epitope constructs and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/677754 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 105 [patent_no_of_words] => 52961 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507803.pdf [firstpage_image] =>[orig_patent_app_number] => 10677754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033530 [patent_doc_number] => 20050032039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'HIV-specific T-cell induction' [patent_app_type] => utility [patent_app_number] => 10/673671 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 35694 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032039.pdf [firstpage_image] =>[orig_patent_app_number] => 10673671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4982772 [patent_doc_number] => 20070087330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Viral deconstruction through capsid assembly in vitro' [patent_app_type] => utility [patent_app_number] => 10/527973 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23340 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087330.pdf [firstpage_image] =>[orig_patent_app_number] => 10527973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630950 [patent_doc_number] => 20060147418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Recombinant double stranded rna phages and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/525702 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17224 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147418.pdf [firstpage_image] =>[orig_patent_app_number] => 10525702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367181 [patent_doc_number] => 20090304740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'MODIFIED HIV ENV POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 10/452018 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 14029 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10452018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4504698 [patent_doc_number] => 07914790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Human IgM antibody lysing activated lymphocytes under mediation by homologous complement' [patent_app_type] => utility [patent_app_number] => 10/520016 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3188 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/914/07914790.pdf [firstpage_image] =>[orig_patent_app_number] => 10520016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831037 [patent_doc_number] => 08859203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Method for typing and detecting HBV' [patent_app_type] => utility [patent_app_number] => 10/606879 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14630 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10606879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7407371 [patent_doc_number] => 20040106105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Vaccine' [patent_app_type] => new [patent_app_number] => 10/462040 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14619 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106105.pdf [firstpage_image] =>[orig_patent_app_number] => 10462040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010814 [patent_doc_number] => 20070281293 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-12-06 [patent_title] => 'Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays' [patent_app_type] => utility [patent_app_number] => 10/447129 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5641 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0281/20070281293.pdf [firstpage_image] =>[orig_patent_app_number] => 10447129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5010814 [patent_doc_number] => 20070281293 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2007-12-06 [patent_title] => 'Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays' [patent_app_type] => utility [patent_app_number] => 10/447129 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5641 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0281/20070281293.pdf [firstpage_image] =>[orig_patent_app_number] => 10447129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829836 [patent_doc_number] => 20030180894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Oligonucleotides and method for characterizing and detecting Genogroup II type small round structured virus' [patent_app_type] => new [patent_app_number] => 10/441126 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7259 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180894.pdf [firstpage_image] =>[orig_patent_app_number] => 10441126 [rel_patent_id] =>[rel_patent_doc_number] =>)